000 | 01295 a2200349 4500 | ||
---|---|---|---|
005 | 20250518050806.0 | ||
264 | 0 | _c20200930 | |
008 | 202009s 0 0 eng d | ||
022 | _a2284-0729 | ||
024 | 7 |
_a10.26355/eurrev_201907_18347 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJin, H | |
245 | 0 | 0 |
_aNew findings of heparanase in human diseases. _h[electronic resource] |
260 |
_bEuropean review for medical and pharmacological sciences _cJul 2019 |
||
300 |
_a5999-6004 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aDisease |
650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
650 | 0 | 4 |
_aGlucuronidase _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 |
_aKidney Diseases _xdrug therapy |
650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNervous System Diseases _xdrug therapy |
650 | 0 | 4 |
_aVirus Diseases _xdrug therapy |
700 | 1 | _aCui, M | |
700 | 1 | _aHu, S-X | |
773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 23 _gno. 13 _gp. 5999-6004 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.26355/eurrev_201907_18347 _zAvailable from publisher's website |
999 |
_c29894058 _d29894058 |